Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Tomas Mikuckis

Partner, Health & Life Sciences, Oliver Wyman

Quality, not quantity, will drive the next wave of partnerships and product launches.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

27 partnered products were launched last year, with 70 percent joint ventured or co-branded insurance products.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

As merger activity heightens, some leverage retail with pharma to meet consumer demand.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

A detailed look at the 22 new payer-provider partnerships created in Q1 this year.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

Earlier this year, we analyzed payer-provider partnerships. As 2017 comes to a close, we consider the year's steady growth and new twists.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman

Insights in your inbox

Subscribe

A detailed look at payer-provider partnerships. Includes new data from Q1 of this year.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

New analysis reveals the pace (rapid) and shape (more joint ventures) of payer-provider partnerships.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman

We highlight how the Medicare Advantage Value-Based Insurance Design Model presents opportunities for both payers and providers.

Global Head, Provider, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman

There have already been 29 payer-provider partnerships announced or launched for 2016-2017, according to our latest tracking report.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Oliver Wyman

Most payer-provider partnerships are still in the test-and-learn phase – adapting their approaches based on local market conditions and stakeholder objectives. However, some key takeaways have emerged.

Head of Health & Life Sciences, North America, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Associate, Oliver Wyman

Insights in your inbox

Subscribe